Catalyst Event
Twist Bioscience Corp (TWST) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
6/2/2026, 12:00:00 AM
Company executives presented at the William Blair 46th Annual Growth Stock Conference on 2026-06-02, reiterating the company's strategy and financial outlook, including the target for adjusted EBITDA breakeven in Q4 2026.
Korean Translation
회사 경영진이 2026년 6월 2일 제46회 윌리엄 블레어 연례 성장주 컨퍼런스에서 발표함. 2026년 4분기 조정 EBITDA 손익분기점 달성 목표 등 회사의 전략과 재무 전망을 재확인함.
Related Recent Events
Pacific Biosciences of California Inc (PACB) · Earnings Release
Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Pharmaron Beijing Co Ltd (3759) · Other
The ex-dividend date for the RMB 0.20 per share final dividend on July 7, 2026, with payment on August 7, 2026; market reaction is estimated at Low as the payout is within expected ranges scheduled.
7/7/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Ex-dividend date on 2026-06-29 for the 2025 final dividend of HK$0.0418 per share; Low importance justified by it being a standard technical adjustment scheduled
6/29/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Annual General Meeting on June 26, 2026, to approve 2025 results and dividends. Analysts estimate a 1-5% price impact for this routine corporate event scheduled.
6/26/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Annual General Meeting on 2026-06-25 to vote on 2025 financial statements and a HK$0.0418 dividend; Low importance justified by the routine nature of the meeting scheduled
6/25/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
An extraordinary general meeting is scheduled on 2026-06-25 to vote on a new executive remuneration system and a 10% H-share repurchase mandate; 1% price impact expected.
6/25/2026, 12:00:00 AM